• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan+
  • Wellness
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Career
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan+
  • Wellness
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Career
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home StudyGraphics

#VisualAbstract: Neoadjuvant HD201 shows similar efficacy to referent trastuzumab for ERBB2-positive breast cancer

byTeddy Guo
April 5, 2022
in StudyGraphics
Reading Time: 1 min read
0
Share on FacebookShare on Twitter

Click to read this study in JAMA Oncology. 

RELATED REPORTS

Pyrotinib in combination with trastuzumab and docetaxel promising for HER2 positive metastatic breast cancer

Sacituzumab govitecan shows survival benefit in endocrine-resistant hormone-positive metastatic breast cancer

Multicancer early detection blood tests show promise but warrant further clinical evaluation

Tags: Breast Cancercardiotoxicityearly breast cancerERBB2-positive breast cancerHD201hematological toxicityHerceptintrastuzumab
Previous Post

Steep decline in post-operative opioid prescriptions for common pediatric surgeries

 Next Post

Bone mineral density testing beneficial for older men receiving androgen deprivation therapy for localized or regional prostate cancer

RelatedReports

Variability in interpretation of breast biopsy slides associated with low verification of atypia and ductal carcinoma in situ
Oncology

Pyrotinib in combination with trastuzumab and docetaxel promising for HER2 positive metastatic breast cancer

November 9, 2023
Preoperative bilateral breast imaging may reduce contralateral cancer recurrence
Chronic Disease

Sacituzumab govitecan shows survival benefit in endocrine-resistant hormone-positive metastatic breast cancer

November 8, 2023
Chronic Disease

Multicancer early detection blood tests show promise but warrant further clinical evaluation

October 18, 2023
Breast cancer chemoprevention may reduce mortality in lobular carcinoma-in-situ
Oncology

Psychological resilience and spiritual well-being may be associated with supportive care needs in breast cancer patients

October 18, 2023
Next Post
Repeat bone mineral density testing may not improve prediction of fracture outcomes

Bone mineral density testing beneficial for older men receiving androgen deprivation therapy for localized or regional prostate cancer

Masks for personal protection for SARS-CoV-2 infection

Oral gefapixant reduces frequency of refractory or unexplained chronic coughs

Oophorectomy associated with reduced cancer risk and all-cause mortality for BRCA1/2 patients

Rapid genotyping for variant associated with aminoglycoside-induced ototoxicity is feasible in acute neonatal setting

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • A Begginer’s Guide to Understanding Odds Ratios, Confidence Intervals, and P-values
  • #VisualAbstract: Intravenous Levothyroxine Does Not Increase the Number of Heart Transplants in Unstable Brain-Dead Potential Heart Donors
  • #VisualAbstract: Dapagliflozin does not reduce albuminuria in patients with heart failure and type 2 diabetes (DAPPER study)
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Career
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options